| 作者 |
 Conference Notice: STAATT III - Alternative Medical Waste Treatment Technologies |
 |
niceshot
[博客]
[个人文集]
游客
|
|
|
作者：游客 在 海归商务 发贴, 来自【海归网】 http://www.haiguinet.com
STAATT (State and Territorial Association for Alternative Treatment Technologies) Third Conference
Host: Florida Department of Health
Date: Dec. 5-7, 2005
Place: Orlando, FL
Attendees: Local, state, federal, and international regulatory contacts/consultants for medical waste management
STAATT
(State and Territorial Association for Alternative Treatment
Technologies) was initially an informal group organized under the
auspices of the EPA in the early ‘90s to devise methods and procedures
for the growing medical waste treatment technology industry. The
initial STAATT I guidance report was released in April of 1994 and has
served many states and countries as a template for their own processes
to evaluate various medical waste treatment systems. In February 1998,
STAATT II was convened to discuss and review the experiences gained
through applying STAATT I and resulted in the release of the STAATT II
guidance document in January of 1999.
Tentative Agenda Topics
A. Efficacy, validation (when sited) and challenge (QC) testing – are required and if so, for all technologies, i.e., chemical vs. heat systems?
B. Efficacy test protocols and procedures:
1.
Identification of worse case scenarios for the two major types of
treatment systems, i.e., chemical and heat – are they the same?
2.
Identification of appropriate test loads for the two major types of
treatment systems – should regulations establish the composition of the
test loads or should this be designated by the vendors of the systems?
3.
Should the recommendations of two biological indicators, i.e.,
bacterial spores and mycobacterial vegetative cells and the level of
inactivation, i.e., 4 log reduction for spores and 6 log inactivation
of vegetative cells be maintained – should this apply to all
technologies and/or for all components of the medical waste stream,
e.g., suction canisters?
4.
Relative to the two indicators, designation of genus and species, as
well as the ATCC or strains from comparable microbiological
collections. Concerning bacterial spores, should consideration be given
to D-values or comparable mechanisms for assessing resistance to
chemical and heat treatment systems, as well as to the use of spore
strips vs. vials and the vendors of spore indicators, e.g., the
utilization of commercial vendors vs. preparation of spore indicators
by test laboratories?
5.
Should tests include the use of untreated controls as bench marks or
base lines for evaluating the actual treatment capabilities and should
this be used for both general types of technologies?
C. Autoclaves
– Discussion of results from ongoing investigations of the application
of autoclaves in the treatment of medical waste – presentations by Sue
Berry, Malcolm Holiday, Ed Krisiunas – implication of the data on
efficacy and challenge testing；
D. Parametric monitoring
– Discussion of the use of monitoring in place of periodic challenge
(QC) testing, consideration of the parameters which should be monitored
with autoclaves, heat and chemical systems, as well as periodic
calibration of the parameters through the use of biological indicators；
E. Biological aerosols and chemical effluent
– Consideration of environmental issues in the approval process
including but not limited to discussion of aerobiology studies of the
areas adjacent to the treatment systems, the application of HEPA and
charcoal filters, negative pressure within the system, balance of air
handling through the technology and/or within the area in which it is
located, chemical and biological testing of liquid discharges, QC of
environmental factors and of equipment use to minimize potential
environmental impact of the use of the equipment；
F. Test laboratories –
general qualifications for laboratories involved in efficacy, challenge
or environmental testing of treatment systems, e.g., ISO or NELAC
certification, technical personnel training, etc.；
G. EPA – Discussion of requirement for registration of chemicals used in treatment of medical waste；
H. Hot topics for future discussions:
1. Biodefense – methods used in treatment of waste generated through biological or chemical incidents；
2. Treatment of chemotherapeutic and pharmaceuticals；
3. New methods for testing biological indicators；
4. Treatment of prion contaminated waste； and
5. Establishment of listserv and exchange of information of use to regulators
欢迎中国从事医疗废物管理，医院管理，环境保护和职业健康政策制定、实施、管理、研究和技术开发的有关人士报名参加。（无报名费，需自付国际旅费和住宿费）。
索取相关信息
Contact Info:
[email protected]
作者：游客 在 海归商务 发贴, 来自【海归网】 http://www.haiguinet.com
|
|
|
| 返回顶端 |
|
 |
|
-
 Conference Notice: STAATT III - Alternative Medical Waste Treatment Technologies -- niceshot - (8945 Byte) 2005-10-19 周三, 03:20 (1022 reads)
|
|
|
|
您不能在本论坛发表新主题, 不能回复主题, 不能编辑自己的文章, 不能删除自己的文章, 不能发表投票, 您 不可以 发表活动帖子在本论坛, 不能添加附件不能下载文件, |
|
|
